SCORR Marketing, the full-service marketing and communications firm in the health science industry, and the Conference Forum, the presenter of strategic-level life science conferences, will collaborate on the 2020 Clinical Research as a Care Option (CRAACO) conference. The Conference Forum will include key initiatives and thought leaders from the Bridging Clinical Research & Clinical Health Care Collaborative at its CRAACO conference.
“We started the Bridging Collaborative in 2018 to bring all stakeholders together to address the gap between clinical research and health care,” said Cinda Orr, CEO at SCORR. “Moving these discussions to CRAACO means the momentum of the Bridging Collaborative will continue as we persist in exploring ways to put patients at the center of research and care.”
Although the Bridging Collaborative is changing, its key areas of focus will continue to be discussed through the CRAACO conference.
“While CRAACO approaches clinical research as a care option from a different viewpoint, we expect this collaboration will make our event stronger by bringing more voices to the conversation,” said Valerie Bowling, executive director of the Conference Forum. “This enhances our ability to facilitate meaningful discussions that ultimately benefit patients.”
CRAACO will be April 27–28, 2020, in Raleigh-Durham, NC.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.